مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

404
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line

Pages

  16-26

Abstract

 Background and Objectives: Non-Hodgkin Lymphoma is one of the common cancers that originates from lymphatic cells. The objective of this study was to assess the effectiveness of the DNAi containing pegylated Nanoliposome (antisense drug) on decrease of bcl-2 gene expression. Methods: In this study, to prepare DNAi containing pegylated Nanoliposome, 3 formulations were prepared with 5, 10, and 15% combinations of PEG 2000 with certain ratios of phospholipid and cholesterols. After purification by a Zetasizer, the mean diameter of Nanoliposome was measured. Drug efficacy was determined based on the standard curve of the drug. Cytotoxicity effect of the product was determined by treatment with 0. 2, 0. 5, and 0. 8μ g/μ l concentrations of each formulation in triplicate in vitro using MTT method. Then, bcl-2 gene expression was analyzed in DLCL2 cell line. Data were analyzed using one way ANOVA. Results: The mean diameter of the DNAi containing pegylated Nanoliposome was estimated to be 117 nm. The mean efficacy of the drug was 67%. The MTT assay on DLCL2 cell line indicated that the highest amount of cell growth inhibition was observed in treatment with pegylated NanoLiposomes 10% (PEG10) and the concentration of 0. 5μ g/μ l. Also, bcl-2 gene expression was significantly decreased in DLCL2 cell line in all concentrations of PEG10 in 48 hours, and the lowest level of bcl-2 gene expression was observed in 0. 5μ g/μ l concentration. Conclusion: PEG10 Nanoliposome formulation has higher efficacy in drug preservation and release compared to other two synthesized Liposomes. It seems that the synthesized Nanoliposome has the potential for using in pharmaceutical industries.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Boozari Saravani, Farahnaz, TAFVIZI, FARZANEH, & JAAFARI, MAHMOUD REZA. (2018). The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line. QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL, 12(10 ), 16-26. SID. https://sid.ir/paper/132065/en

    Vancouver: Copy

    Boozari Saravani Farahnaz, TAFVIZI FARZANEH, JAAFARI MAHMOUD REZA. The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line. QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL[Internet]. 2018;12(10 ):16-26. Available from: https://sid.ir/paper/132065/en

    IEEE: Copy

    Farahnaz Boozari Saravani, FARZANEH TAFVIZI, and MAHMOUD REZA JAAFARI, “The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line,” QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL, vol. 12, no. 10 , pp. 16–26, 2018, [Online]. Available: https://sid.ir/paper/132065/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top